Companies Reporting Before The Bell
• AstraZeneca (NASDAQ:AZN) is expected to report quarterly earnings at $0.67 per share on revenue of $11.21 billion.
In a turnaround from 2022, analysts have again begun to show improved regard for real estate investment trusts (REITs). While downgrades and lowered price targets dominated REIT news last year, more analysts have been upgrading them since the beginning of 2023.
The prevailing wisdom on Wall Street is that recessions follow massive interest rate hikes, as high-interest rates slow down sales of real estate, automobiles and credit card spending on nonessential retail goods.
Income investors love receiving dividends to pay regular bills, but too often quarterly dividends are paid in bunches, rather than being spread out across each month.
Every so often an investor comes across two stocks that are both high-quality performers and also pay solid dividends. Then the most difficult part is figuring out which one is the better buy.